Last reviewed · How we verify

NCT03781830

mDOT for Immunosuppressant Adherence in Adolescent Liver Transplant Recipients

Withdrawn NA Last updated 21 September 2021
What this trial tests

NA trial testing mHealth Intervention in Medication Adherence. Withdrawn.

Timeline
18 June 2020
Primary endpoint
12 November 2020
12 November 2020

Quick facts

Lead sponsorJohns Hopkins University
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Start date18 June 2020
Primary completion12 November 2020
Estimated completion12 November 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Johns Hopkins University

Who can join

Adults 14 to 21, any sex, with Medication Adherence or Liver Transplantation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators are interested in whether or not the use of a mobile health (mHealth) application increases the rate of immunosuppression medication adherence among adolescent liver transplant recipients. The investigators aim to test this by recruiting adolescent (ages 14-21) liver transplant recipients to use an mHealth application to record themselves taking their immunosuppression medications, and tracking medication adherence over time. The study population will be approximately 25 adolescent liver transplant recipients at the Johns Hopkins Hospital.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of mHealth Intervention

Trials testing the same drug.

Other recruiting trials for Medication Adherence

Currently open trials in the same condition.

Other Johns Hopkins University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03781830.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing